Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 12
2004 10
2005 10
2006 13
2007 11
2008 13
2009 15
2010 12
2011 8
2012 8
2013 14
2014 8
2015 9
2016 12
2017 15
2018 9
2019 12
2020 9
2021 13
2022 10
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
A naturally occurring variant of SHLP2 is a protective factor in Parkinson's disease.
Kim SJ, Miller B, Hartel NG, Ramirez R 2nd, Braniff RG, Leelaprachakul N, Huang A, Wang Y, Arpawong TE, Crimmins EM, Wang P, Sun X, Liu C, Levy D, Yen K, Petzinger GM, Graham NA, Jakowec MW, Cohen P. Kim SJ, et al. Among authors: cohen p. Mol Psychiatry. 2024 Jan 3. doi: 10.1038/s41380-023-02344-0. Online ahead of print. Mol Psychiatry. 2024. PMID: 38167865
Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection.
Hanson BA, Visvabharathy L, Orban ZS, Jimenez M, Batra A, Liotta EM, DeLisle RK, Klausner JD, Cohen P, Padhye AS, Tachas G, Koralnik IJ. Hanson BA, et al. Among authors: cohen p. Brain Behav Immun. 2023 Nov;114:462-474. doi: 10.1016/j.bbi.2023.08.022. Epub 2023 Sep 11. Brain Behav Immun. 2023. PMID: 37704012 Free article.
Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center: Structure, Innovations, and Initial Outcomes.
Reams RR, Odedina FT, Carpten JD, Redda K, Stern MC, Krieger JL, Aparicio J, Hensel B, Askins N, Abreu A, Adams A, Agyare E, Ali J, Allen JM, Aló R, Baezconde-Garbanati L, Brant J, Brown CP, Buxbaum SG, Cohen P, Cozen W, Ezenwa MO, Falzarano S, Fillingim RB, Flores-Rozas H, Fredenburg KM, George T, Han B, Huang Y, Hughes Halbert C, Kiros GE, Lamango NS, Lee JH, Lyon DE, Mitchell DA, Mochona B, Nieva JJ, Offringa IA, Okunieff P, Parker A, Rhie SK, Richey JM, Rogers SC, Salhia B, Schmittgen TD, Segal R, Setiawan VW, Smith U, Su LM, Suther S, Trevino J, Velazquez-Villarreal EI, Webb FJ, Wu AH, Yao Y, Wilkie DJ. Reams RR, et al. Among authors: cohen p. Cancer Control. 2023 Jan-Dec;30:10732748231197878. doi: 10.1177/10732748231197878. Cancer Control. 2023. PMID: 37703814 Free PMC article. Review.
Correction: Mitochondrial DNA variation in Alzheimer's disease reveals a unique microprotein called SHMOOSE.
Miller B, Kim SJ, Mehta HH, Cao K, Kumagai H, Thumaty N, Leelaprachakul N, Braniff RG, Jiao H, Vaughan J, Diedrich J, Saghatelian A, Arpawong TE, Crimmins EM, Ertekin-Taner N, Tubi MA, Hare ET, Braskie MN, Décarie-Spain L, Kanoski SE, Grodstein F, Bennett DA, Zhao L, Toga AW, Wan J, Yen K, Cohen P; Alzheimer’s Disease Neuroimaging Initiative. Miller B, et al. Among authors: cohen p. Mol Psychiatry. 2023 Apr;28(4):1827. doi: 10.1038/s41380-023-01956-w. Mol Psychiatry. 2023. PMID: 36658336 No abstract available.
212 results